Tofase 11 ER contains Tofacitinib Citrate 11 mg Extended-Release (ER), a targeted immunomodulator designed to manage rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. By inhibiting Janus kinase (JAK) enzymes, Tofacitinib helps reduce joint inflammation, pain, and swelling, improving mobility and quality of life.

The extended-release formulation ensures once-daily dosing, convenient for long-term treatment while maintaining consistent therapeutic levels in the body.

Key Benefits:

• Reduces joint pain, stiffness, and swelling in rheumatoid and psoriatic arthritis

• Supports improved mobility and daily functioning

• Helps manage ulcerative colitis symptoms

• Extended-release formulation allows convenient once-daily dosing

• Enhances overall quality of life for chronic inflammatory conditions

How to Use:

• Take one tablet daily, with or without food, as prescribed by your physician.

• Swallow whole with water; do not crush or chew.

• Do not exceed the prescribed dose.